Cytovation and SMS-oncology Sign Agreement on Conduct of Phase I/II Trial With CyPep-1 in Solid Tumors |
| August 09, 2019 | August 2019 Bond Updates |
|
BERGEN, Norway and SCHIPHOL, The Netherlands, Aug. 9, 2019 /PRNewswire/ -- Cytovation AS ("Cytovation") and Specialized Medical Services-oncology BV ("SMS-oncology") today announce that SMS-oncology has been selected as the CRO to conduct the phase I/II clinical trial with CyPep-1 in... |
| View more at: https://www.prnewswire.com:443/news-releases/cytovation-and-sms-oncology-sign-agreement-on-conduct-of-phase-iii-trial-with-cypep-1-in-solid-tumors-300899333.html |